RSVP by Tuesday, December 17, 2013 12:00 p.m.
Where Hyatt Regency La Jolla
3777 La Jolla Village Drive
San Diego, California 92122
What the FDA Says, What the Company Hears: Successful Communication with the Agency
Finally, on December 18, Biocom will bring back one of its most popular breakfast topics ever, "What the FDA Says, What the Company Hears." This will be a highly interactive session discussing the challenges and opportunities of dealing with the FDA, both from a company perspective and the perspective of those who have been on the reviewer side of the table.
Lisa Haile, Partner, Co-Chair, Global Life Sciences Sector, DLA Piper
Michele Yelmene, Head of Biotech Division at Pharmalink Consulting
EJ Brandreth, Senior Vice President, Quality and Regulatory Affairs, Ajinomoto Althea
John F. Wood, MBA, RAC, Vice President, Regulatory Affairs, Arena Pharmaceuticals, Inc.
Planner Ashleigh Berry